Alyeska Investment Group’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Hold
1,663,355
﹤0.01% 501
2025
Q1
$1.02M Hold
1,663,355
﹤0.01% 433
2024
Q4
$1.75M Sell
1,663,355
-300
-0% -$315 0.01% 468
2024
Q3
$3.26M Sell
1,663,655
-271,829
-14% -$533K 0.02% 384
2024
Q2
$3.85M Buy
+1,935,484
New +$3.85M 0.02% 354